Tag : Presented

Cardiology

Ankle-Brachial Index in Addition to Stress Testing in Patients Who Presented With Chest Pain and 1-Year Major Cardiovascular Events.

Newsemia
Related Articles Ankle-Brachial Index in Addition to Stress Testing in Patients Who Presented With Chest Pain and 1-Year Major Cardiovascular Events. Crit Pathw Cardiol. 2019...
Latest News

VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $VBIV–VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that updated Part...
Latest News

Onduo Data Presented at American Diabetes Association’s (ADA) 80th Scientific Sessions Highlights Meaningfully Lowered Hemoglobin A1C in People with T2D, with Significantly Greater Reductions in Participants Using Continuous Glucose Monitoring

Newsemia
BOSTON–(BUSINESS WIRE)– #ADA2020–This week Onduo presented research results at the American Diabetes Association’s (ADA) 80th Scientific Sessions: A Virtual Experience demonstrating continued and meaningful improvement...
Latest News

Bristol-Myers Squibb Announces Studies Evaluating liso-cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology (ASH) Annual Meeting

Newsemia
PRINCETON, N.J.–(BUSINESS WIRE)—- $BMY–Studies Evaluating Liso-Cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology Source link...
Latest News

Positive Data from First Clinical Study of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor Designed for First Point-of-Contact STEMI Therapy, Presented at AHA 2019 Late-Breaking Science Session

Newsemia
SAN DIEGO–(BUSINESS WIRE)–Data from a completed clinical study show RUC-4 provided a potent, rapid, and sustained platelet inhibition effect in stable CAD patients w/aspirin. Source...
Gastroenterology

New Clinical Advances in Gastroenterology Presented at the American College of Gastroenterology's 84th Annual Scientific Meeting

Newsemia
The American College of Gastroenterology Annual Scientific Meeting features innovative clinical gastroenterology research with implications for patients with digestive and liver diseases. ACG’s Public Relations...
Latest News

New Data Presented at World Sleep Congress Demonstrate Early Signs of Efficacy for TAK-925, a Selective Orexin Type-2 Receptor (OX2R) Agonist, in Patients with Narcolepsy Type 1

Newsemia
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) announced results of a Phase 1 clinical proof of concept study of the novel...
Latest News

Spectrum Pharmaceuticals Announces Integrated Results from Two Phase 3 ROLONTIS® (eflapegrastim) Trials Being Presented at the ASCO Annual Meeting

Newsemia
HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals Announces Integrated Results from Two Phase 3 ROLONTIS® (eflapegrastim) Trials Being Presented at the ASCO Annual Meeting Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World